Streetbeat News

Earnings

INPX

Inpixon (NASDAQ:INPX) reported a narrower adjusted EPS loss of $(0.08) in Q3 compared to $(0.84) in the same quarter last year, indicating an improvement in profitability. However, sales declined to $2.02M from $2.44M year-over-year, reflecting a decrease in revenue.

Portfolio Pulse from mahesh@benzinga.com

November 14, 2023 | 9:33 pm

VRAR

Glimpse Group (NASDAQ:VRAR) reported Q1 EPS of $(0.01), surpassing the $(0.18) estimate, and sales of $3.10M, exceeding the $3.00M estimate. This reflects a significant reduction in losses compared to the previous year, but a decrease in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:33 pm

TIVC

Tivic Health Systems (NASDAQ:TIVC) reported Q3 earnings with a loss of $(1.48) per share, significantly beating the $(7.00) estimate. Despite the improvement over last year's $(27.00) loss per share, the company's sales of $282.00K fell short of the expected $780.00K, marking a 40.88% decrease from the previous year's sales.

Portfolio Pulse from totan@benzinga.com

November 14, 2023 | 9:33 pm

ALC

Alcon reported Q3 core earnings per share (EPS) of $0.66, slightly below the expected $0.67. Sales were reported at $2.3 billion, which also fell short of the estimated $2.349 billion.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:32 pm

REBN

Reborn Coffee, Inc. (NASDAQ:REBN) reported a Q3 EPS loss of $(0.23), a 15% increase in loss compared to $(0.20) in the same quarter last year. However, sales rose significantly by 71.91% to $4.09M from $2.38M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:32 pm

GVP

GSE Systems (NASDAQ:GVP) reported Q3 adjusted EPS of $(0.07), surpassing the $(0.60) estimate, marking an 88.33% beat and an 86% improvement from last year's $(0.50) per share. However, sales of $11.57M fell short of the $12.44M estimate by 7.03%, and also saw a 2.79% decline from the previous year's $11.90M.

Portfolio Pulse from bharat@benzinga.com

November 14, 2023 | 9:31 pm

YTEN

Yield10 Bioscience (NASDAQ:YTEN) reported a Q3 2023 EPS loss of $(0.41), missing the consensus estimate of $(0.39) by 5.13%. However, this represents a 42.25% improvement from the $(0.71) per share loss in the same quarter last year.

Portfolio Pulse from vinayak@benzinga.com

November 14, 2023 | 9:31 pm

TNON

Tenon Medical (NASDAQ:TNON) reported Q3 earnings with a loss of $(1.46) per share, outperforming the $(2.80) estimate, marking a 48.23% improvement from the previous year. However, sales of $944.00K fell short of the $1.07M estimate, despite being a 353.85% increase from the same period last year.

Portfolio Pulse from totan@benzinga.com

November 14, 2023 | 9:31 pm

ATNF

PXMD

RNLX

SPRO

THRX

XGN

In Tuesday's after-market session, several healthcare stocks experienced significant movements. Theseus Pharmaceuticals (THRX) saw a 34.1% increase, while PaxMedica (PXMD) rose by 19.87%. 180 Life Sciences (ATNF) went up by 17.94% following their Q3 earnings release 3 days prior. Exagen (XGN) and Renalytix (RNLX) also saw gains after their recent earnings reports. Spero Therapeutics (SPRO) increased by 8.1% post Q3 earnings. Conversely, Harrow (HROW) dropped by 22.1%, Tenax Therapeutics (TENX) by 15.89%, Beyond Air (XAIR) by 13.8%, Owlet (OWLT) by 12.55%, TRACON Pharma (TCON) by 10.15%, and Inspire Veterinary (IVP) by 9.8% after their earnings reports.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 9:31 pm

POLA

Polar Power reported a 12% year-over-year increase in net sales for Q3, reaching $1.9M. However, the company experienced a loss, with an EPS of $(0.14).

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 9:31 pm